Dopamine-sensitive adenylyl cyclases in neuronal development: physiopathological and pharmacological implications.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Drug Discovery Today

• Publication date

  2011-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.drudis.2011.03.010PMID 21477663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of an Adenylyl Cyclase Inhibitor for Treating Neuropathic and Inflammatory Pain

  2011cited by this paper
• L-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata.

  2011cited by this paper
• Nerve Growth Factor-Induced Differentiation of PC12 Cells Is Accompanied by Elevated Adenylyl Cyclase Activity

  2010cited by this paper
• Novel adenosine and cAMP signalling pathways in migrating glial cells.

  2010cited by this paper
• Roles of db-cAMP, IBMX and RA in Aspects of Neural Differentiation of Cord Blood Derived Mesenchymal-Like Stem Cells

  2010cited by this paper
• The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits.

  2010cited by this paper
• Differentiation of mouse Neuro 2A cells into dopamine neurons.

  2010cited by this paper
• Direct conversion of fibroblasts to functional neurons by defined factors

  2010cited by this paper
• Dopamine D1, D2 and mu-opioid receptors are co-expressed with adenylyl cyclase 5 and phosphodiesterase 7B mRNAs in striatal rat cells.

  2010cited by this paper
• Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits.

  2010cited by this paper
• Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs

  2010cited by this paper
• Stem cell-derived dopamine neurons for brain repair in Parkinson's disease.

  2010cited by this paper
• In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.

  2009cited by this paper
• Adenylyl cyclase type 5 protein expression during cardiac development and stress.

  2009cited by this paper
• Altered growth factor signaling pathways as the basis of aberrant stem cell maturation in schizophrenia.

  2009cited by this paper
• Antipsychotic drug actions on gene modulation and signaling mechanisms.

  2009cited by this paper
• In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.

  2009cited by this paper
• Adenylyl cyclases as innovative therapeutic goals.

  2009cited by this paper
• Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles

  2009cited by this paper
• Capturing adenylyl cyclases as potential drug targets

  2009cited by this paper
• Response to Histamine Allows the Functional Identification of Neuronal Progenitors, Neurons, Astrocytes, and Immature Cells in Subventricular Zone Cell Cultures

  2008cited by this paper
• Ascorbic acid is a regulator of the intracellular cAMP concentration: Old molecule, new functions?

  2008cited by this paper
• Adenylyl cyclase‐5 activity in the nucleus accumbens regulates anxiety‐related behavior

  2008cited by this paper
• “Soluble” adenylyl cyclase‐generated cyclic adenosine monophosphate promotes fast migration in PC12 cells

  2008cited by this paper
• Activation and Inhibition of Adenylyl Cyclase Isoforms by Forskolin Analogs

  2008cited by this paper
• Brain uptake of an anti-ischemic agent by nasal administration of microparticles.

  2008cited by this paper
• Schizophrenia: From genes to phenes to disease

  2008cited by this paper
• Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood.

  2008cited by this paper
• Identification of a forskolin-like molecule in human renal cysts.

  2007cited by this paper
• Adenylyl cyclase-dependent axonal targeting in the olfactory system

  2007cited by this paper
• Differential development of neuronal physiological responsiveness in two human neural stem cell lines

  2007cited by this paper
• The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.

  2007cited by this paper
• Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123.

  2007cited by this paper
• Drug therapy aimed at adenylyl cyclase to regulate cyclic nucleotide signaling.

  2006cited by this paper
• Cellular Localisation of Adenylyl Cyclase: A Post-genome Perspective

  2006cited by this paper
• Gene expression profiling and analysis of signaling pathways involved in priming and differentiation of human neural stem cells.

  2006cited by this paper
• Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.

  2006cited by this paper
• Research update: neurogenesis in adult brain and neuropsychiatric disorders.

  2006cited by this paper
• Regulation of multiple dopamine signal transduction molecules by retinoids in the developing striatum.

  2005cited by this paper
• Adult retinal pigment epithelium cells express neural progenitor properties and the neuronal precursor protein doublecortin.

  2005cited by this paper
• Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development.

  2005cited by this paper
• Pharmaceutical applications of embryonic stem cells.

  2005cited by this paper
• Mechanisms and perspectives on differentiation of autonomic neurons.

  2005cited by this paper
• Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies

  2005cited by this paper
• Differential expression of adenylyl cyclase subtypes in human cardiovascular system.

  2004cited by this paper
• A role for chemistry in stem cell biology

  2004cited by this paper
• Brain dopamine‐stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

  2004cited by this paper
• Multi‐modal regulation of endogenous D1 dopamine receptor expression and function in the CAD catecholaminergic cell line

  2004cited by this paper
• Differential Inhibition of Adenylyl Cyclase Isoforms and Soluble Guanylyl Cyclase by Purine and Pyrimidine Nucleotides*

  2004cited by this paper
• Differentiation‐induced alterations in cyclic AMP signaling in the Cath.a differentiated (CAD) neuronal cell line

  2004cited by this paper
• Brain Targeting Of Nerve Growth Factor Using Poly(Butylcyanoacrylate) Nanoparticles

  2004cited by this paper
• Activity-dependent homeostatic specification of transmitter expression in embryonic neurons

  2004cited by this paper
• Hydroxamate based inhibitors of adenylyl cyclase. Part 1: the effect of acyclic linkers on P-site binding.

  2003cited by this paper
• Transcriptional Up-regulation of Endothelial Cell Matrix Metalloproteinase-2 in Response to Extracellular Cues Involves GATA-2*

  2003cited by this paper
• Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions.

  2003cited by this paper
• The neurodevelopmental hypothesis of schizophrenia: a review of recent developments

  2003cited by this paper
• Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells.

  2003cited by this paper
• Schizophrenia: from phenomenology to neurobiology

  2003cited by this paper
• Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment.

  2003cited by this paper
• Regulation and organization of adenylyl cyclases and cAMP.

  2003cited by this paper
• Motor Dysfunction in Type 5 Adenylyl Cyclase-null Mice*

  2003cited by this paper
• Isoform-specific regulation of adenylyl cyclase: a potential target in future pharmacotherapy

  2003cited by this paper
• Receptor heteromerization in adenosine A2A receptor signaling

  2003cited by this paper
• A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease.

  2003cited by this paper
• Metal coordination-based inhibitors of adenylyl cyclase: novel potent P-site antagonists.

  2003cited by this paper
• Glutamate, Dopamine, and Schizophrenia

  2003cited by this paper
• 2′(3′)-O-(N-Methylanthraniloyl)-substituted GTP Analogs: A Novel Class of Potent Competitive Adenylyl Cyclase Inhibitors*

  2003cited by this paper
• Hydroxamate based inhibitors of adenylyl cyclase. Part 2: the effect of cyclic linkers on P-site binding.

  2002cited by this paper
• Activation of protein kinase A induces neuronal differentiation of HiB5 hippocampal progenitor cells.

  2002cited by this paper
• Impaired D2 Dopamine Receptor Function in Mice Lacking Type 5 Adenylyl Cyclase

  2002cited by this paper
• Olfactory Neural Cells: An Untapped Diagnostic and Therapeutic Resource

  2002cited by this paper
• Dopamine as a prolactin (PRL) inhibitor.

  2001cited by this paper
• Type-specific Regulation of Adenylyl Cyclase

  2001cited by this paper
• Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature

  2001cited by this paper
• D2/D3 Dopamine Receptor Heterodimers Exhibit Unique Functional Properties*

  2001cited by this paper
• Anatomy and function of dopamine receptors: understanding the pathophysiology of fluctuations in Parkinson's disease.

  2001cited by this paper
• In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP.

  2001cited by this paper
• D(1) receptors in prefrontal cells and circuits.

  2000cited by this paper
• Regulation of adenylyl cyclase in the central nervous system.

  2000cited by this paper
• Coupling of dopamine receptor subtypes to multiple and diverse G proteins

  2000cited by this paper
• Why stem cells?

  2000cited by this paper
• Inhibition by Calcium of Mammalian Adenylyl Cyclases*

  1999cited by this paper
• The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease.

  1999cited by this paper
• Association of prenatal and perinatal complications with subsequent bipolar disorder and schizophrenia.

  1999cited by this paper
• Orchestration of neuronal migration by activity of ion channels, neurotransmitter receptors, and intracellular Ca2+ fluctuations.

  1998cited by this paper
• Forskolin derivatives with increased selectivity for cardiac adenylyl cyclase.

  1998cited by this paper
• Different expression of adenylyl cyclase isoforms after retinoic acid induction of P19 teratocarcinoma cells

  1997cited by this paper
• Priming of 6-hydroxydopamine-lesioned rats with L-DOPA or quinpirole results in an increase in dopamine D1 receptor-dependent cyclic AMP production in striatal tissue.

  1997cited by this paper
• Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor.

  1997cited by this paper
• Genes and parkinsonism.

  1997cited by this paper
• Differential Expression of Type I, II, and V Adenylyl Cyclase Gene in the Postnatal Developing Rat Brain

  1997cited by this paper
• Type V, but not type VI, adenylyl cyclase mRNA accumulates in the rat heart during ontogenic development. Correlation with increased global adenylyl cyclase activity.

  1995cited by this paper
• Voltage-sensitive Adenylyl Cyclase Activity in Cultured Neurons. A CALCIUM-INDEPENDENT PHENOMENON (*)

  1995cited by this paper
• Perinatal risk factors and schizophrenia: selective review and methodological concerns.

  1995cited by this paper
• Selective expression of one Ca(2+)-inhibitable adenylyl cyclase in dopaminergically innervated rat brain regions.

  1994cited by this paper
• Positron emission tomographic evidence for progression of human MPTP‐induced dopaminergic lesions

  1994cited by this paper
• Cloning and expression of an adenylyl cyclase localized to the corpus striatum

  1993cited by this paper
• Ageing and Parkinson's disease: substantia nigra regional selectivity.

  1991cited by this paper
• Dopamine receptor subtype imbalance in schizophrenia.

  1987cited by this paper
• Modifications of the adenylate cyclase complex during differentiation of cultured myoblasts

  1986cited by this paper

• Potential therapeutic effects of odorants through their ectopic receptors in pigmented cells.

  2017cites this paper
• Piperonal attenuates visceral adiposity in mice fed a high-fat diet: potential involvement of the adenylate cyclase-protein kinase A dependent pathway.

  2017cites this paper
• Meglumine cyclic adenylate improves neurological function following acute spinal cord injury in rats.

  2014cites this paper
• Induction of bone marrow stromal cells into GABAergic neuronal phenotype using creatine as inducer

  2012cites this paper